This morning Lund-based drug developer RhoVac released its year-end report. CEO Anders Månsson visited BioStock’s studio to tell us more about the company’s challenges and achievements during 2020 as well as the company’s development plan going forward. Månsson points out that the company has entered 2021 on solid ground and with strong finances, and is … Fortsätt läsa BioStock Studio: RhoVac’s CEO comments on the year-end report